Novartis AG
SIX:NOVNEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVNEE
|
CH |
|
W
|
Walt Disney Co
DUS:WDP
|
US |
|
A
|
Annaly Capital Management Inc
F:AAY
|
US |
|
H
|
Henkel AG & Co KGaA
XBER:HEN
|
DE |
|
N
|
Novartis AG
SWB:NOTA
|
CH |
|
Taskus Inc
NASDAQ:TASK
|
US |
|
Welltower Inc
NYSE:WELL
|
US |
|
P
|
PDF Solutions Inc
F:PD9
|
US |
|
T
|
Texas Instruments Inc
BMV:TXN
|
US |
|
S
|
Starbucks Corp
F:SRB
|
US |
Wall St Price Targets
NOVNEE Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOVNEE is 124.56 CHF with a low forecast of 92.01 CHF and a high forecast of 147.16 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVNEE's stock price target?
Price Target
124.56
CHF
According to Wall Street analysts, the average 1-year price target for NOVNEE is 124.56 CHF with a low forecast of 92.01 CHF and a high forecast of 147.16 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
